We evaluated a three-marker model comprising serum CA19-9 in combination with the plasma proteins ITIH3 and CEACAM1 for pancreatic ductal adenocarcinoma (PDAC) detection. The gene discussed is CEACAM1; the disease is pancreatic ductal adenocarcinoma.